Data coverage, completeness and provenance for MIRO SCIENCES LTD in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T05:10:11. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0500 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0530 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0540 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0540 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0520 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/MSX/prices · Price parameters and adjustment semantics
No archived filings are currently stored for this listing.
Miro Sciences Ltd engages in the research and development of biomedical products targeting neurodegenerative conditions and immune-mediated inflammatory diseases. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. Miro Sciences Ltd was formerly known NeuroScientific Biopharmaceuticals Limited and change its name to Miro Sciences Ltd in October 2026. The company was incorporated in 2002 and is based in Perth, Australia.
Website: https://www.neuroscientific.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/MSX/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 23 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 24 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 25 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 22 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 5 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/MSX
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/MSX/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/MSX/metrics/summary
Dated press releases and announcements with source links.
GET /api/v1/companies/MSX/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/MSX
Free tier — instant API key. Built for AI agents.